INS and Glucose intolerance: High blood glucose levels and glucose intolerance, as a consequence of a defective insulin production/secretion by pancreatic β cells (β-cells) or insulin sensitivity (Stumvoll et al., 2005; Tan et al., 2019), are the typical clinical features of the disease.